Immunology Research

Janssen is committed to helping ease the battle that people living with immune-mediated inflammatory diseases have to endure for the rest of their lives.

We have a strong history of delivering biological medicines for immunological diseases and we continue to build a pipeline of exciting, new biotechnological products, while expanding into small-molecule oral medications and broadening our disease focus in autoimmune and inflammatory diseases.

Our goal at Janssen is to improve the diagnosis of immune-mediated inflammatory diseases, improve patients’ access to the best possible treatments and continue to provide new and better medicines.

We never underestimate the human impact of immune-mediated inflammatory diseases

People living with immune-mediated inflammatory diseases can face a lifetime of managing their condition, yet the impact of these diseases is dramatically underestimated. As some of these diseases are not readily recognised, people can suffer silently before eventually receiving treatment.

Our mission is clear: we won’t rest until we achieve a world free from immune-mediated inflammatory diseases.

Our disease areas of focus are Dermatology, Rheumatology, Gastroenterology, Psoriasis, Psoriastic Arthritis and Inflammatory Bowel Disease

CP-346502 | September 2022